Form 4: Cigna CEO David Cordani Trades Shares

Cigna Group CEO David Cordani reported a series of stock transactions on May 12-13, 2026, primarily involving the sale of common stock.

Summary

• David Cordani, Chairman & CEO of The Cigna Group, executed several transactions involving common stock on May 12 and May 13, 2026.
• These transactions were conducted under a Rule 10b5-1 trading plan established on February 6, 2026.
• The transactions included both acquisitions and dispositions of common stock, with sales occurring at prices ranging from $286.43 to $298.675 per share.
• Cordani's beneficial ownership of common stock, both direct and indirect, is detailed, including holdings through a GRAT, a Trust, and a 401(k) plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports routine insider stock transactions conducted under a pre-established trading plan, without indicating significant positive or negative developments for the company.

Future Outlook

The filing does not contain forward-looking statements or guidance. It reports on past transactions.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into the trading activities of company executives and directors. The use of a Rule 10b5-1 plan indicates a pre-arranged strategy for stock sales, often employed to avoid concerns about insider trading.

Key Dates

Keywords

Form 4, SEC Filing, Insider Trading, Stock Transaction, Cigna Group, David Cordani, Rule 10b5-1, Common Stock, Beneficial Ownership